taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

taRgeting bEtA-Cell Function To achIeVe Remission of Type 2 diAbeTEs — Stella

Home/Type 2 Diabetes/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Addenbrooke's Hospital NHS Foundation Trust, Cambridge, Cambridgeshire

Key details

Sponsor

University of Cambridge

Collaborators

Cambridge University Hospitals NHS Foundation Trust

Enrollment target

~56 participants

Started

April 2025

Primary completion

December 2028

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.